Abstract
"Outsourcing defines future of Euro Bioinformatics market" "Jump on
bioinformatics bandwagon"
These are just two newspaper headlines that appeared today. Managing your data
is critical to your organisation. You already know that. But is your company
doing it as effectively as it should? Find out by reading this brand new
report.
This report delivers answers on how you can benefit from the commercial
prospects of bioinformatics, now. The ultimate goal of bioinformatics is to
uncover the wealth of biological information hidden in the mass of data, to
obtain a clearer insight into the fundamental biology of organisms. Is your
Bioinformatic strategy working to the maximum level. These recent developments
have a profound relevance to pharmaceutical development.
These technological solutions are now a vital part of pharmaceutical R&D,
enabling researchers to store, interpret and apply increasing volumes of data.
We forecast that bioinformatics will exhibit steady growth in revenues from
2006-2011, with significant investments being made by companies in the
pharmaceutical sector. Key technological challenges - such as harnessing
information from The Human Genome Project - will drive that expansion. Are you
directing your investments in the right way? Is your data working for you
effectively? This report will tell you.
This in-depth report for senior management examines pharmaceutical
applications of bioinformatics critically, through in-depth primary and
secondary research, Interviews with the industry's leading strategists,
questionnaires and industry polls. Plus through continuous consultation with
experts in industry and academia, this research involved a detailed study of
policy documents, industrial reports and relevant news. We have also applied
techniques such as financial forecasting, SWOT analyses and qualitative
projections, as well as our in-house GO forecasting tool. The result is a
comprehensive market-based report with detailed analysis and informed opinion.
In particular, this report concentrates on the following essential aspects of
bioinformatic solutions in the pharmaceutical sector:
- Innovative technologies that drive the bioinformatics industry
- Key industrial players in bioinformatics - including partnerships in this
field
- Forecasts of the bioinformatics market from 2006-2011, including forecasts
of principal market segments and geographical regions
- Drivers and opportunities for you in the bioinformatics sector
- Restraints and threats in the bioinformatics sector and how to avoid them
- Assessments of relevant business models, technological solutions and
associated issues
- Coverage of academic developments and future trends in the sector -
possible partnerships?
- Interviews with key figures and wide ranging insight from leading experts
Why you must buy this report today:
- To receive a comprehensive analysis of the prospects for bioinformatic
solutions in the pharmaceutical sector from 2006-2011
- To discover predicted revenues, growth rates and other key metrics for
bioinformatic solutions from 2006-2011
- To receive the views of experts on bioinformatics in both industry and
academia
- To determine the forces that influence the market for bioinformatics with
pharmaceutical applications:
- Competitive characteristics of the market
- Drivers
- Restraints
- Strengths, weaknesses, opportunities and threats
- To find out where bioinformatics is heading - both technologically and
commercially
Unique benefits
- Full searchable report when you buy the company or corporate editions
- Immediate access through our exclusive Reading Room
- You can access your report whichever country you are in without using hard
drive space
- Primary research throughout. You will not find this information anywhere
else
- Report stored in your reading room for ever
- Copies can be printed off for offline reading
- Packed with charts, analysis, figures, graphs and tables
- Full after purchase care and analyst assistance
View Cart
